Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 4
1994 3
1995 2
1996 5
2001 1
2002 1
2004 1
2006 1
2009 1
2010 2
2011 2
2014 4
2015 4
2016 8
2017 2
2018 3
2019 2
2020 5
2021 9
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
Quagliariello V, De Laurentiis M, Rea D, Barbieri A, Monti MG, Carbone A, Paccone A, Altucci L, Conte M, Canale ML, Botti G, Maurea N. Quagliariello V, et al. Among authors: maurea n. Cardiovasc Diabetol. 2021 Jul 23;20(1):150. doi: 10.1186/s12933-021-01346-y. Cardiovasc Diabetol. 2021. PMID: 34301253 Free PMC article.
Moreover, pro-inflammatory studies were also performed: expression of NLRP3 inflammasome, MyD88 myddosome and p65/NF-kappaB associated to secretion of cytokines involved in cardiotoxicity (Interleukins 1beta, 8, 6). C57Bl/6 mice were untreated (Sham, n = 6) or treated for …
Moreover, pro-inflammatory studies were also performed: expression of NLRP3 inflammasome, MyD88 myddosome and p65/NF-kappaB associated to se …
Pathophysiology of anthracycline cardiotoxicity.
Mele D, Tocchetti CG, Pagliaro P, Madonna R, Novo G, Pepe A, Zito C, Maurea N, Spallarossa P. Mele D, et al. Among authors: maurea n. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e3-e11. doi: 10.2459/JCM.0000000000000378. J Cardiovasc Med (Hagerstown). 2016. PMID: 27755237 Review.
Pathophysiology of anthracycline cardiotoxicity.
Mele D, Tocchetti CG, Pagliaro P, Madonna R, Novo G, Pepe A, Zito C, Maurea N, Spallarossa P. Mele D, et al. Among authors: maurea n. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S3-S11. doi: 10.2459/JCM.0000000000000378. J Cardiovasc Med (Hagerstown). 2016. PMID: 27183523 Review.
Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19.
Quagliariello V, Paccone A, Iovine M, Cavalcanti E, Berretta M, Maurea C, Canale ML, Maurea N. Quagliariello V, et al. Among authors: maurea n, maurea c. Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6797-6812. doi: 10.26355/eurrev_202111_27124. Eur Rev Med Pharmacol Sci. 2021. PMID: 34787884 Free article. Review.
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
Maurea N, Spallarossa P, Cadeddu C, Madonna R, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Tocchetti CG, Zito C, Mercuro G. Maurea N, et al. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1(Suppl 1):S93-S104. doi: 10.2459/JCM.0000000000000383. J Cardiovasc Med (Hagerstown). 2016. PMID: 27183530 Free PMC article. Review.
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
Maurea N, Spallarossa P, Cadeddu C, Madonna R, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Tocchetti CG, Zito C, Mercuro G. Maurea N, et al. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e93-e104. doi: 10.2459/JCM.0000000000000383. J Cardiovasc Med (Hagerstown). 2016. PMID: 27755247 Review.
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
Spallarossa P, Maurea N, Cadeddu C, Madonna R, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Tocchetti CG, Zito C, Mercuro G. Spallarossa P, et al. Among authors: maurea n. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1(Suppl 1):S84-92. doi: 10.2459/JCM.0000000000000381. J Cardiovasc Med (Hagerstown). 2016. PMID: 27183529 Free PMC article. Review.
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
Spallarossa P, Maurea N, Cadeddu C, Madonna R, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Tocchetti CG, Zito C, Mercuro G. Spallarossa P, et al. Among authors: maurea n. J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection:e84-e92. doi: 10.2459/JCM.0000000000000381. J Cardiovasc Med (Hagerstown). 2016. PMID: 27755246 Review.
63 results